The rise and fall of peptic ulceration: a disease of civilization?

Gastrointestinal DiseasesInflammatory Bowel Disease

Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials

Lancet Gastroenterol Hepatol.

Scally B, Emberson JR, Spata E, Reith C, Davies K, Halls H, Holland L, Wilson K, Bhala N, Hawkey C, Hochberg M, Hunt R, Laine L, Lanas A, Patrono C, Baigent C

doi: 10.1016/S2468-1253

Inflammatory Bowel Disease

Scoring systems for peptic ulcer bleeding: Which one to use?

World J Gastroenterol.

Budimir I, Stojsavljević S, Baršić N, Bišćanin A, Mirošević G, Bohnec S, Kirigin LS, Pavić T, Ljubičić N

doi: 10.3748/wjg.v23.i41.7450.

Helicobacter PyloriInflammatory Bowel Disease

Factors Associated With Adherence to Helicobacter pylori Testing During Hospitalization for Bleeding Peptic Ulcer Disease

Clin Gastroenterol Hepatol.

Hung KW, Knotts RM, Faye AS, Pont AR, Lebwohl B, Abrams JA, Freedberg DE

doi: 10.1016/j.cgh.2019.07.037.

Helicobacter Pylori

Helicobacter pylori-associated peptic ulcer disease: A retrospective analysis of post-treatment testing practices

Helicobacter.

Feder R, Posner S, Qin Y, Zheng J, Chow SC, Garman KS

doi: 10.1111/hel.12540.

Inflammatory Bowel Disease

Validation of the "German Inflammatory Bowel Disease Activity Index (GIBDI)": An Instrument for Patient-Based Disease Activity Assessment in Crohn's Disease and Ulcerative Colitis

Z Gastroenterol.

Hüppe A, Langbrandtner J, Häuser W, Raspe H, Bokemeyer B

doi: 10.1055/a-0605-4080.

Inflammatory Bowel Disease

PR3-ANCA and panel diagnostics in pediatric inflammatory bowel disease to distinguish ulcerative colitis from Crohn's disease

PLoS One.

Horn MP, Peter AM, Righini Grunder F, Leichtle AB, Spalinger J, Schibli S, Sokollik C

doi: 10.1371/journal.pone.

Inflammatory Bowel Disease

Contribution of Helicobacter pylori infection to the risk of peptic ulcer bleeding in patients on nonsteroidal anti-inflammatory drugs, antiplatelet agents, anticoagulants, corticosteroids and selective serotonin reuptake inhibitors

Aliment Pharmacol Ther.

Venerito M, Schneider C, Costanzo R, Breja R, Röhl FW, Malfertheiner P

doi: 10.1111/apt.14652.

Gastrointestinal Diseases

Peptic Ulcer Disease as a Common Cause of Bleeding in Patients with Coronavirus Disease 2019

No abstract available

Surgical repair of perforated peptic ulcers: laparoscopic versus open approach

Surg Endosc.

Vakayil V, Bauman B, Joppru K, Mallick R, Tignanelli C, Connett J, Ikramuddin S, Harmon JV Jr

doi: 10.1007/s00464-018-6366-y.

Related content

Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials

Scoring systems for peptic ulcer bleeding: Which one to use?

Factors Associated With Adherence to Helicobacter pylori Testing During Hospitalization for Bleeding Peptic Ulcer Disease

Helicobacter pylori-associated peptic ulcer disease: A retrospective analysis of post-treatment testing practices

Validation of the "German Inflammatory Bowel Disease Activity Index (GIBDI)": An Instrument for Patient-Based Disease Activity Assessment in Crohn's Disease and Ulcerative Colitis

PR3-ANCA and panel diagnostics in pediatric inflammatory bowel disease to distinguish ulcerative colitis from Crohn's disease

Contribution of Helicobacter pylori infection to the risk of peptic ulcer bleeding in patients on nonsteroidal anti-inflammatory drugs, antiplatelet agents, anticoagulants, corticosteroids and selective serotonin reuptake inhibitors

Peptic Ulcer Disease as a Common Cause of Bleeding in Patients with Coronavirus Disease 2019

Surgical repair of perforated peptic ulcers: laparoscopic versus open approach